Developments and Advances in Medical Management of Diabetes

Morbidity from diabetes involves both macrovascular (atherosclerosis) and microvascular (retinopathy, nephropathy, and neuropathy) diseases. Interventions can limit organ damage and, therefore, patients with diabetes require initial and ongoing evaluation for diabetes-related complications. Weight management and the prevention of cardiovascular morbidity is a major priority for patients with diabetes, especially type 2 diabetes mellitus (T2DM). This session will analyze why glycemic control is important in the long term to reduce the onset and severity of the complications of type 2 diabetes, as well as to reduce macrovascular risk. It will also discuss the significant metabolic benefit of medications that are used to aid in weight loss in the management of diabetes and review medical management approaches consistent with guidelines from the American Diabetes Association (ADA) for health maintenance in patients with diabetes.

Learning Objectives
At the end of this educational activity, participants should be able to

  1. Review the mechanism of action and therapeutic utility of DPP-4 inhibitors and SGLT1 receptor agonists for the treatment of T2DM
  2. Explain how SGLT2 inhibitors could dramatically improve glycemic control in type 2 diabetes and how this new class of drugs may boost overall health by promoting weight loss
  3. Recognize why glycemic control is important in the long term to reduce the onset and severity of the complications of T2DM, as well as to reduce macrovascular risk
  4. List drugs that are used to aid weight loss in the management of diabetes, and state the significant metabolic benefits of these medications
  5. Discuss the increasing focus on a personalized approach in determining the degree of blood sugar control in this patient population

Faculty Listing
Anne Peters, MD
Director, USC Clinical Diabetes Programs
Professor
Keck School of Medicine of USC
Beverly Hills, CA

Disclosures of Relevant Financial Relationships
In accordance with the ACCME Standards for Commercial SupportSM, OptumHealth Education requires all those involved in the development of activity content to disclose their relevant financial relationships. An individual has a relevant financial relationship if such person (or their spouse/partner) has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the activity content over which the individual has control.
OptumHealth Education ensures that the content is independent of commercial bias.

Faculty Disclosure
Dr Peters discloses the following: Bigfoot Biomedical, Omada Health, Thermalin (Advisory Board/Consultant); Medtronic Foundation (Grant/Research Support).

Activity Planners
Michael Abecassis, MD, MBA
Northwestern University
Chicago, IL

Sarah Chart, RN
OptumHealth Education
Eden Prairie, MN

Rebecca Gleason, RN, CCM
OptumHealth Education
Eden Prairie, MN

Dixon B. Kaufman, MD, PhD, FACS
University of Wisconsin School of Medicine and Public Health
Madison, WI

C. Fred LeMaistre, MD
Sarah Cannon
Nashville, TN

Tina Rydland, PharmD
Crystal Clear Rx
Denver, CO

V. Silverstein, MD
Eagle Creek Medical Communications
Durham, NC

Activity Planner Disclosures
Drs Abecassis, Kaufman, LeMaistre, Rydland and Silverstein have indicated that they have no relevant financial relationships.
Ms Chart and Ms Gleason have indicated that they are employees of and own stock in UnitedHealth Group.

Reviewer Disclosures
To ensure fair balance and avoid bias, the content for this activity has been reviewed by an independent medical expert with no relevant financial relationships.

Method of Participation
There are no fees for participating in or receiving credit for this activity.
For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

Participants will receive a certificate upon successful completion of the activity, which includes the following:

  • Completing the entire activity
  • Completing the Pre- and Post-Activity Assessments, Activity Evaluation, and Application for Certificate of Credit forms

You must be logged into your account to participate in this activity. Get started by clicking “Begin” and viewing the “CE Info”; then follow the prompts at the bottom of the screen. At the end of the activity, you will be able to view, save, or print your certificate of participation. The Area of Practice you indicated in your profile corresponds with your certificate type. A complete listing of all of your activities can be found under “My Account”, “My Activities.”

Method for Calculating CE Credit
CE credit was calculated by the complexity of content.

Accreditation Statement
Joint Accreditation LogoIn support of improving patient care, OptumHealth Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the health care team.

Credit Designation Statements
Physicians
OptumHealth Education designates this enduring activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physician Assistants
The American Academy of Physician Assistants (AAPA) accepts credit from organizations accredited by the ACCME.

Nurses
The participant will be awarded up to 1.00 contact hour(s) of credit for attendance and completion of supplemental materials.

Nurse Practitioners
The American Academy of Nurse Practitioners Certification Program (AANPCP) accepts credit from organizations accredited by the ACCME and ANCC.

Case Managers
The Commission for Case Manager Certification has approved this program for a maximum of 1.00 clock hour(s) for Certified Case Managers (CCM). (Please reference the 25th Annual National Conference when contacting CCMC to claim credit for this activity.)

Pharmacists/Pharmacy Technicians
This activity is approved for 1.00 contact hour(s) ([0.1] CEU) in states that recognize ACPE.
Attending the full program will earn 1.00 contact hour(s).
Unique Activity Number(s): 0860-0000-16-011-H01P/0860-0000-16-011-H01T

Attendance
A certificate of attendance will be provided to learners upon completion of activity requirements, enabling participants to register with licensing boards or associations that have not been pre-approved for credits. To apply for credit types not listed above, participants should use the procedure established by the specific organization to which you wish you apply credit.

Provided By
This activity is provided by OptumHealth Education.

Commercial Support
No commercial support was received for this activity.

Hardware/Software Requirements
To view this activity you will need Internet Explorer 7.0+ or Firefox 3.0+ with Windows Media Player 9+, RealPlayer 12+, or Adobe Flash Player 9+. Be sure to disable your pop-up blocking software prior to the beginning of this activity.

Target Audience

This activity is designed to meet the educational needs of case managers, nurses, pharmacists, pharmacy technicians, physicians and other health care professionals who are interested in diabetes.

This activity consists of recorded presentations from the "25th Annual National Conference" held in Minneapolis, MN on October 5–7, 2016.

Activity summary
Available credit: 
  • 1.00 ACPE - Pharmacist
  • 1.00 ACPE - Pharmacy Technician
  • 1.00 AMA
  • 1.00 ANCC
  • 1.00 Attendance
  • 1.00 CCMC - General
Activity opens: 
11/14/2016
Activity expires: 
11/14/2018
Rating: 
0

Available Credit

  • 1.00 ACPE - Pharmacist
  • 1.00 ACPE - Pharmacy Technician
  • 1.00 AMA
  • 1.00 ANCC
  • 1.00 Attendance
  • 1.00 CCMC - General
Please login to register.